Zoetis | ZTS - Selling And Administration Expenses


Zoetis reported $588M in Selling and Administration Expenses for its fiscal quarter ending in March of 2026.





Selling And Administration Expenses Change Date
AbbVie USD 3.63B 54M Jun/2026
Align Technology USD 462.67M 2.67M Jun/2026
Bayer EUR 3.7B 356M Mar/2026
Bristol-Myers Squibb USD 1.83B 209M Jun/2026
Charles River Laboratories USD 159.42M 36.71M Mar/2026
Coherus Biosciences USD 15M 6.26M Dec/2025
Dentsply International USD 351M 32M Mar/2026
Eli Lilly USD 2.93B 198M Mar/2026
Henry Schein USD 831M 22M Jun/2026
Idexx Laboratories USD 288.09M 11.76M Jun/2026
Illumina USD 273M 1000K Jun/2026
IQVIA Holdings USD 574M 72M Jun/2026
J&J USD 6.42B 381M Jun/2026
Laboratory Of America USD 577.2M 26.2M Jun/2026
Merck USD 2.67B 180M Mar/2026
Neogen USD 99.8M 1.3M Mar/2026
Pacira USD 83.88M 7.99M Mar/2026
Perrigo USD 267.3M 11.4M Mar/2026
Pfizer USD 3.41B 496M Jun/2026
Phibro Animal Health USD 78.32M 10.24M Dec/2025
Quest Diagnostics USD 529M 25M Jun/2026
Sanofi EUR 2.63B 307M Jun/2026
Sanofi EUR 2.49B 252M Mar/2026
Zoetis USD 588M 31M Mar/2026